Trial Profile
Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- 31 Dec 2019 Status changed from active, no longer recruiting to discontinued.
- 05 Feb 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 02 Feb 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.